The treatment of advanced non-small-cell lung cancer (NSCLC)--overseas updated and local experiences.
Chu
Da-Tong
DT
Cancer Institute and Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100021.
Zhang
Xiang-Ru
XR
Li
Jun-Ling
JL
Qu
Feng-Lian
FL
Sun
Yan
Y
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality; D002945:Cisplatin / Q000008:administration & dosage; D017326:Clinical Trials, Phase III as Topic; D015251:Epirubicin / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D016685:Mitomycin / Q000008:administration & dosage; D015996:Survival Rate
D015251:Epirubicin; D016685:Mitomycin; D002945:Cisplatin; D007069:Ifosfamide